AEON Biopharma, Inc. (NYSE AMERICAN: AEON)
$0.1050
-0.0220 ( -13.08% ) 9.1M
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Market Data
Open
$0.1050
Previous close
$0.1270
Volume
9.1M
Market cap
$10.16M
Day range
$0.1020 - $0.1340
52 week range
$0.1020 - $17.1700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Dec 20, 2024 |
| 10-q | Quarterly Reports | 78 | Nov 13, 2024 |
| 8-k | 8K-related | 16 | Nov 13, 2024 |
| 8-k | 8K-related | 40 | Oct 07, 2024 |
| 4/a | Other | 1 | Sep 10, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |